Related Experiment Video
Updated: Jun 12, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Non-tobacco nicotine use and the risk of cataract development
Nathan Vu Pham1, Emery Dutta2, Thalia H Nguyen1
1David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Purpose:
To examine the relationship between non-tobacco nicotine product (NTNP) exposure and the risk of cataract development and cataract surgery.
Design:
A retrospective analysis of aggregated healthcare data within the TriNetX U.S. Collaborative Network METHODS: We identified patients with documented exposure to NTNPs (n = 107,462) and control patients (n = 2,512,152) without exposure. NTNP exposure was defined as having had a vaping-related or unspecified nicotine dependence diagnosis. Patients with pre-existing lens disorders, ocular trauma, or procedures were excluded. Propensity score matching (1:1) was performed, accounting for demographics, cataract risk factors, and comorbidities. We assessed the risk of developing cataracts and receiving cataract surgery. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated.
Results:
After PSM, the exposure and control groups had mean ages of 50.8 ± 15.7 vs 51.8 ± 16.8 years, 61% vs 62% White, and 50% vs 50% female. Compared to matched controls (n = 106,116), patients exposed to NTNPs (n = 106,116) had an increased risk of developing cataracts (HR 2.21; 95% CI 2.12-2.31). Of the patients who received a cataract diagnosis, NTNP exposure was associated with higher risk of receiving cataract surgery (HR 2.93; 95% CI 2.77-3.09) within 5 years.
Conclusion:
NTNP usage may be associated with cataract development. Given their widespread use in recent years, they may pose considerable public health risks, and it would be prudent to further investigate their relationship with cataracts.
More Related Videos
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Photoreceptors and Visual Pathways
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Cancer Prevention
Some...

